Evaluation of a Mobile Application for Patients and Clinical Decision-making Support Tools for Prescribers to Decrease Opioid Misuse and Habit-forming Behaviors Following Post-operative Prescription
对患者移动应用程序和处方者临床决策支持工具的评估,以减少术后处方后阿片类药物滥用和习惯形成行为
基本信息
- 批准号:10613515
- 负责人:
- 金额:$ 67.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Absence of pain sensationAdherenceAffectAlgorithmsAnti-Inflammatory AgentsBehaviorCessation of lifeClientClinicalCommunicationCommunitiesComputer softwareDataData AnalyticsData Management ResourcesData ReportingDatabasesDevicesDistressDoseDrug KineticsEcosystemElectronicsEpidemicEuphoriaEvaluationFeedbackFundingHabitsHealth Insurance Portability and Accountability ActHeroinHeroin UsersInterventionMeasuresModelingMonitorMorphineOpioidOrganismOutcomeOutcome MeasureOverdosePainPain managementPatient MonitoringPatient Self-ReportPatientsPatternPersonsPharmaceutical PreparationsPharmacodynamicsPhasePhysiciansPostoperative PainPostoperative PeriodProviderPublic HealthRecordsRegimenReportingScheduleSignal TransductionSmall Business Innovation Research GrantSupport SystemSymptomsSystemTestingTimeWithdrawalclinical decision supportclinical decision-makingdashboarddata managementdata portaldata visualizationdigital platformdrug seeking behaviorexperienceimprovedinnovationmedication compliancemilligrammobile applicationopioid epidemicopioid misuseopioid useopioid use disorderpain reliefpain scorepatient engagementpatient portalpatient-clinician communicationpharmacodynamic modelpharmacokinetics and pharmacodynamicsprecision medicineprescription opioidpreventprovider portalreal time monitoringsatisfactionsuccesssupport toolssystem architecturetreatment planningusability
项目摘要
PROJECT SUMMARY/ABSTRACT
Opioid misuse is an epidemic and a public health crisis. At least 2 million people have an opioid use
disorder (OUD) involving prescription opioids, and 600,000 have heroin OUD6. Alarmingly, 80% of heroin users
used prescription opioids before transitioning to heroin7. It is therefore critical to ensure that opioid pain
therapies are administered safely, in a way that minimizes the potential for aberrant drug related behaviors.
This necessitates individualized opioid regimens and strict adherence, enabling effective pain control without
producing euphoria or withdrawals, both of which can lead to drug seeking behaviors. Continuous Precision
Medicine (CPM) aims to develop a software ecosystem to reduce opioid misuse and over-prescription
in postoperative patients. In a self-funded Phase I, we have developed clinical decision support software,
which consists of a server for data management and analytics and a mobile client application for the patient.
The digital platform delivers a personalized schedule, records dosing and pain levels, and motivates
adherence to dosing by scoring compliance. In this project, we propose to evaluate and improve the CPM suite
of clinical decision support tools and provide clinicians and patients with immediately actionable information to
decrease over-prescription and misuse of opioids during the post-operative period. In the proposed Phase II
SBIR project, CPM will refine and evaluate the mobile application, deploy and test a Prescriber Portal with
dashboard functions to enable physicians to overlay pharmacokinetic and pharmacodynamic modeling to
improve prescribing practices and deter drug-habit-forming behavior, and prepare materials for a 501(k)
application submission. The CPM app, patient data, and provider portal, taken together and optimally
employed to improve patient-provider communication and treatment planning, has the potential to prevent
negative sequelae associated with over-prescription and misuse of opioids, including opioid use
disorder, overdose, and death.
项目总结/摘要
阿片类药物滥用是一种流行病,也是一场公共卫生危机。至少有200万人使用阿片类药物
涉及处方阿片类药物的OUD,60万人患有海洛因OUD 6。令人担忧的是,80%的海洛因使用者
在过渡到海洛因之前使用处方阿片类药物7。因此,确保阿片类药物疼痛
以最小化异常药物相关行为的可能性的方式安全地施用治疗。
这需要个体化的阿片类药物治疗方案和严格的依从性,使有效的疼痛控制,
产生欣快感或戒断症状,两者都可能导致寻求药物的行为。连续精度
医学(CPM)旨在开发一个软件生态系统,以减少阿片类药物滥用和过度处方
术后患者。在自筹资金的第一阶段,我们开发了临床决策支持软件,
其由用于数据管理和分析的服务器和用于患者的移动的客户端应用程序组成。
数字平台提供个性化的时间表,记录剂量和疼痛水平,并激励
通过对依从性进行评分来确定给药依从性。在这个项目中,我们建议评估和改进CPM套件
临床决策支持工具,并为临床医生和患者提供可立即采取行动的信息,
减少术后期间阿片类药物的过度处方和滥用。在拟议的第二阶段
SBIR项目,CPM将完善和评估移动的应用程序,部署和测试处方者门户,
仪表板功能,使医生能够叠加药代动力学和药效学建模,
改善处方实践,阻止吸毒成瘾行为,并为501(k)准备材料
申请提交。CPM应用程序、患者数据和提供商门户网站,以最佳方式结合在一起
用于改善患者-提供者沟通和治疗计划,有可能预防
与过量处方和滥用阿片类药物(包括使用阿片类药物)相关的负面后遗症
紊乱过量和死亡
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Walther其他文献
Steven Walther的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Walther', 18)}}的其他基金
Evaluation of a Mobile Application for Patients and Clinical Decision-making Support Tools for Prescribers to Decrease Opioid Misuse and Habit-forming Behaviors Following Post-operative Prescription
对患者移动应用程序和处方者临床决策支持工具的评估,以减少术后处方后阿片类药物滥用和习惯形成行为
- 批准号:
10390242 - 财政年份:2022
- 资助金额:
$ 67.84万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
Fellowship Programs